QurAlis
Shafique Virani, MD FRCS, currently serves as Chief Business Officer at NOETIK and as a member of the Board of Directors at QurAlis. With extensive experience in the biopharmaceutical industry, Shafique has held various leadership roles, including Non-Executive Director at TauC3 Biologics and Senior Strategic Advisor at Recursion. As former CEO of CoA Therapeutics and Navire Pharma, Shafique successfully led the development of innovative therapies targeting neurological diseases and cancers. Other notable positions include CEO in Residence at BridgeBio LLC and Vice President of Business Development at Roche/Genentech, where Shafique contributed to building a leading portfolio in neuroscience and rare diseases through strategic partnerships and acquisitions. Shafique's educational background includes degrees from the University of Cambridge, Royal College of Surgeons of England, and University of Nottingham.
This person is not in any teams
This person is not in any offices
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.